3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
199
Leukemia, Lymphocytic, Chronic, B-Cell
169
Leukemia
165
Myelodysplastic Syndromes
162
Precursor Cell Lymphoblastic Leukemia-Lymphoma
151
Lymphoma, Non-Hodgkin
129
Lymphoma
120
Multiple Myeloma
112
Hodgkin Disease
110
Lymphoma, Follicular
97
Lymphoma, Mantle-Cell
95
Lymphoma, Large B-Cell, Diffuse
87
Lymphoma, B-Cell, Marginal Zone
79
Myeloproliferative Disorders
77
Burkitt Lymphoma
75
Congenital Abnormalities
73
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
67
Leukemia, Myelomonocytic, Chronic
66
Leukemia, Myeloid, Chronic-Phase
64
Leukemia, Myeloid, Accelerated Phase
62
Recurrence
57
Lymphoma, Large-Cell, Immunoblastic
55
Waldenstrom Macroglobulinemia
50
Anemia, Refractory, with Excess of Blasts
50
Primary Myelofibrosis
48
Neoplasms, Plasma Cell
47
Blast Crisis
47
Hematologic Neoplasms
40
Leukemia, Prolymphocytic
37
Dendritic Cell Sarcoma, Interdigitating
37
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Chickenpox
×
fludarabine phosphate
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled